Tuesday, May 19, 2020 8:24:19 AM
[quote ] RBL??? calling the RBL?!? green monkey cells- been there and done that. Instead of getting the data we have waited 18 days for now we are given other data about green monkey kidney epithelial cells.
RBL testing on lung cell cultures are not mentioned at all, nothing. Why? [/quote]
A lot of warning signs in this PR. We were told it would be human lung cells not VERO cells / preincubation with 10uM is testing you’d do for vaccine-like properties, we want to know how B works on infected human lung cells as a treatment / they announced it will no longer be pursued as a vaccine despite testing its vaccine-like properties / is 10uM a safe dosage? and what route? We don’t know because it’s in-vitro / the PR ends with asking for email inquiries for partners and additional research, if this is showing so much promise why is there no partner yet? / again the phrase rapidly advance into human trials is used and has been used for the last 2 months and not only has that not happened we don’t even have any data on human lung cells in vitro.
Why no compassionate care designation to get some human trials going?
Hoping this PR gets the stock to finally get back into the .20’s and any positive news is good but there’s a lot of snake oil warning signs here.
Cmon IPIX!
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM